<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Referred-in-Senate" bill-type="olc" dms-id="HFC8BB162C10344B584C71F76A493C9C6" public-private="public" stage-count="1">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 HR 4701 : Tick-Borne Disease Research Accountability and Transparency Act of 2014</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2014-09-10</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">IIB</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 4701</legis-num>
		<current-chamber display="yes">IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action><action-date date="20140910">September 10, 2014</action-date><action-desc>Received; read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>AN ACT</legis-type>
		<official-title display="yes">To provide for research with respect to Lyme disease and other tick-borne diseases, and for other
			 purposes.</official-title>
	</form>
	<legis-body id="HD4C7F4AA13CF40E096E48C7C6E590F31" style="OLC">
		<section commented="no" id="HEA1C1F5299174152870BB7A9BC668B6C" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Tick-Borne Disease Research Accountability and Transparency Act of 2014</short-title></quote>.</text>
		</section><section commented="no" id="H588F264FCAE443ABB8CE3D478AC9AA98"><enum>2.</enum><header>Lyme disease and other tick-borne diseases</header><text display-inline="no-display-inline">Title III of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/241">42 U.S.C. 241 et seq.</external-xref>) is amended by adding at the end
			 the following new part:</text>
			<quoted-block display-inline="no-display-inline" id="H0F0A80DEAB9544E2A2BE3273FA5DECEA" style="OLC">
				<part commented="no" id="H8FABDDAC96FC45DFAC67A4B2AC58C2CE"><enum>W</enum><header>Lyme disease and other tick-borne diseases</header>
					<section commented="no" id="H92DE1573679649499877F69DBB2789F4"><enum>399OO.</enum><header>Research</header>
						<subsection commented="no" id="H7009955CEE724C0DB96D09B79FAFE3F1"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall conduct or support epidemiological, basic, translational, and clinical research
			 regarding Lyme disease and other tick-borne diseases.</text>
						</subsection><subsection commented="no" id="H6B81811EB5154BA58069CADCC1C06007"><enum>(b)</enum><header>Biennial reports</header><text>The Secretary shall ensure that each biennial report under section 403 includes information on
			 actions undertaken by the National Institutes of Health to carry out
			 subsection (a) with respect to Lyme disease and other tick-borne diseases,
			 including an assessment of the progress made in improving the outcomes of
			 Lyme disease and such other tick-borne diseases.</text>
						</subsection></section><section commented="no" id="H1A427E1A0A36427F9F541A3D1EB4DC85"><enum>399OO–1.</enum><header>Working Group</header>
						<subsection commented="no" id="H9B0B29A41BFD439AA994F6DCF45D367A"><enum>(a)</enum><header>Establishment</header><text display-inline="yes-display-inline">The Secretary shall establish a permanent working group, to be known as the Interagency Lyme and
			 Tick-Borne Disease Working Group (in this section and section 399OO–2
			 referred to as the <quote>Working Group</quote>), to review all efforts within the Department of Health and Human Services concerning Lyme disease
			 and other tick-borne diseases to ensure interagency coordination, minimize
			 overlap, and examine research priorities.</text>
						</subsection><subsection commented="no" id="H1C9B74F6C3A94A60B22371F7A093FD2C"><enum>(b)</enum><header>Responsibilities</header><text>The Working Group shall—</text>
							<paragraph commented="no" id="H0C2F65662A1446C1919F3747E082E429"><enum>(1)</enum><text>not later than 24 months after the date of enactment of this part, and every 24 months thereafter,
			 develop or update a summary of—</text>
								<subparagraph commented="no" id="H0C743F2BFEFB49119B3C64F0897A40CA"><enum>(A)</enum><text>ongoing Lyme disease and other tick-borne disease research related to causes, prevention,
			 treatment, surveillance, diagnosis, diagnostics, duration of illness,
			 intervention, and access to services and supports for individuals with
			 Lyme disease or other tick-borne diseases;</text>
								</subparagraph><subparagraph commented="no" id="HA65145A8E3D64A99AC7D4BE53ECCC99E"><enum>(B)</enum><text>advances made pursuant to such research;</text>
								</subparagraph><subparagraph commented="no" id="H16A7C5B3827E4CEBAA36788F77A04A46"><enum>(C)</enum><text display-inline="yes-display-inline">the engagement of the Department of Health and Human Services with persons that participate at the
			 public meetings required by paragraph (5); and</text>
								</subparagraph><subparagraph commented="no" id="H85EEC97D5CA2479B881B1B00AEC8C2FB"><enum>(D)</enum><text>the comments received by the Working Group at such public meetings and the Secretary’s response to
			 such comments;</text>
								</subparagraph></paragraph><paragraph commented="no" id="HB0C9135252C44BECA49572065E5CE5F5"><enum>(2)</enum><text>ensure that a broad spectrum of scientific viewpoints is represented in each such summary;</text>
							</paragraph><paragraph commented="no" id="H252B4BA446E8489CBC50CB0F8413EC8D"><enum>(3)</enum><text>monitor Federal activities with respect to Lyme disease and other tick-borne diseases;</text>
							</paragraph><paragraph commented="no" id="H75994866AA6642368CBDD352CD60C11C"><enum>(4)</enum><text>make recommendations to the Secretary regarding any appropriate changes to such activities; and</text>
							</paragraph><paragraph commented="no" id="HF26DA7F295F34807923E2E5B215E21B6"><enum>(5)</enum><text>ensure public input by holding annual public meetings that address scientific advances, research
			 questions, surveillance activities, and emerging strains in species of
			 pathogenic organisms.</text>
							</paragraph></subsection><subsection commented="no" id="HE9277FB2541D4D4A8A4C849B262625A8"><enum>(c)</enum><header>Membership</header>
							<paragraph commented="no" id="HDF60DF91DEEA4B4DAE3FB18764120EF5"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">The Working Group shall be composed of a total of 14 members as follows:</text>
								<subparagraph commented="no" id="H74B4D3B0561446BD92C964F7092BD308"><enum>(A)</enum><header>Federal members</header><text>Seven Federal members, consisting of one or more representatives of each of—</text>
									<clause commented="no" id="HB0960CA1C6D546A082FB2FAC9C77B9B1"><enum>(i)</enum><text>the Office of the Assistant Secretary for Health;</text>
									</clause><clause commented="no" id="H291E9392D3E94462B6EA569BD278C1BB"><enum>(ii)</enum><text>the Food and Drug Administration;</text>
									</clause><clause commented="no" id="H42F036A501694BE8AAFFBF1A45A9DC24"><enum>(iii)</enum><text>the Centers for Disease Control and Prevention;</text>
									</clause><clause commented="no" id="H03DB357DF59A4096ADD394277376DF9E"><enum>(iv)</enum><text>the National Institutes of Health; and</text>
									</clause><clause commented="no" id="HE19189B4F1D447F6B808866FB98514F4"><enum>(v)</enum><text>such other agencies and offices of the Department of Health and Human Services as the Secretary
			 determines appropriate.</text>
									</clause></subparagraph><subparagraph commented="no" id="H701570741BA84D539CB566F477141C17"><enum>(B)</enum><header>Non-Federal public members</header><text>Seven non-Federal public members, consisting of representatives of the following categories:</text>
									<clause commented="no" id="H84C78ABFDF2E4BEB96800E5780637CAA"><enum>(i)</enum><text>Physicians and other medical providers with experience in diagnosing and treating Lyme disease and
			 other tick-borne diseases.</text>
									</clause><clause commented="no" id="H73FE9FD584D34B539F60573E9DF61A80"><enum>(ii)</enum><text>Scientists or researchers with expertise.</text>
									</clause><clause commented="no" id="H4EDC6DAE77E44F0BBBB4FA8E31AC0CEC"><enum>(iii)</enum><text>Patients and their family members.</text>
									</clause><clause commented="no" id="HBA6AA1E4435E47EBBBA29E91E602A96B"><enum>(iv)</enum><text display-inline="yes-display-inline">Nonprofit organizations that advocate for patients with respect to Lyme disease and other
			 tick-borne diseases.</text>
									</clause><clause commented="no" id="H6407515DDBD14474AD4578BA652710E1"><enum>(v)</enum><text>Other individuals whose expertise is determined by the Secretary to be beneficial to the
			 functioning of the Working Group.</text>
									</clause></subparagraph></paragraph><paragraph commented="no" id="H8EEEBF22DEAE4019B8A097551BA413C9"><enum>(2)</enum><header>Appointment</header><text>The members of the Working Group shall be appointed by the Secretary, except that of the
			 non-Federal public members under paragraph (1)(B)—</text>
								<subparagraph commented="no" id="HBB71BD67FAB044AFA3AA7A9A17DACEB5"><enum>(A)</enum><text display-inline="yes-display-inline">one shall be appointed by the Speaker of the House of Representatives; and</text>
								</subparagraph><subparagraph commented="no" id="HBE3B26DB3AAD4164BAAAB53B9CE0D950"><enum>(B)</enum><text>one shall be appointed by the Majority Leader of the Senate.</text>
								</subparagraph></paragraph><paragraph commented="no" id="H54DD242E1FE04D91A05E3657CF3430B9"><enum>(3)</enum><header>Diversity of scientific perspectives</header><text display-inline="yes-display-inline">In making appointments under paragraph (2), the Secretary, the Speaker of the House of
			 Representatives, and the Majority Leader of the Senate shall ensure that
			 the non-Federal public members of the Working Group represent a diversity
			 of scientific perspectives.</text>
							</paragraph><paragraph commented="no" id="H77878D105FDE43B9BC4A56BC36B2527D"><enum>(4)</enum><header>Terms</header><text>The non-Federal public members of the Working Group shall each be appointed to serve a 4-year term
			 and may be reappointed at the end of such term.</text>
							</paragraph></subsection><subsection commented="no" id="HFE8F363EAF444DD49E78CA97B78E30EC"><enum>(d)</enum><header>Meetings</header><text>The Working Group shall meet as often as necessary, as determined by the Secretary, but not less
			 than twice each year.</text>
						</subsection><subsection id="H2645F1000F9E4347B75131C36A53C320"><enum>(e)</enum><header>Applicability of FACA</header><text>The Working Group shall be treated as an advisory committee subject to the Federal Advisory
			 Committee Act.</text>
						</subsection><subsection commented="no" id="H5AB774426D414EE09D60DF219E7816FF"><enum>(f)</enum><header>Reporting</header><text display-inline="yes-display-inline">Not later than 24 months after the date of enactment of this part, and every 24 months thereafter,
			 the Working Group—</text>
							<paragraph commented="no" id="H4B2B70B5A4224AD5AF8195DECB86EF29"><enum>(1)</enum><text>shall submit a report on its activities, including an up-to-date summary under subsection (b)(1)
			 and any recommendations under subsection (b)(4), to the Secretary, the
			 Committee on Energy and Commerce of the House of Representatives, and the
			 Committee on Health, Education, Labor and Pensions of the Senate;</text>
							</paragraph><paragraph commented="no" id="H73FF19A3AED8438EB94E38E1E8E8C2FD"><enum>(2)</enum><text>shall make each such report publicly available on the website of the Department of Health and Human
			 Services; and</text>
							</paragraph><paragraph commented="no" id="HC40C4526A17F452D887A4CB68C216AD5"><enum>(3)</enum><text>shall allow any member of the Working Group to include in any such report minority views.</text>
							</paragraph></subsection></section><section commented="no" id="H3DCD951EA6664CA388304E3FBE52F760"><enum>399OO–2.</enum><header>Strategic plan</header><text display-inline="no-display-inline">Not later than 3 years after the date of enactment of this section, and every 5 years thereafter,
			 the Secretary shall submit to the Congress a strategic plan, informed by
			 the most recent summary under section 399OO–1(b)(1), for the conduct and
			 support of Lyme disease and tick-borne disease research, including—</text>
						<paragraph commented="no" id="H00D0C78313E246F285029D8B804A18FC"><enum>(1)</enum><text>proposed budgetary requirements;</text>
						</paragraph><paragraph commented="no" id="H61FDE7BE1B914DA5807B58F7CFE2C60F"><enum>(2)</enum><text display-inline="yes-display-inline">a plan for improving outcomes of Lyme disease and other tick-borne diseases, including progress
			 related to chronic or persistent symptoms and chronic or persistent
			 infection and co-infections;</text>
						</paragraph><paragraph commented="no" id="H1525181D2D1E4D1AAAFCF17219857B26"><enum>(3)</enum><text>a plan for improving diagnosis, treatment, and prevention;</text>
						</paragraph><paragraph commented="no" id="H91E0CAFFAC8D4346931A7F79B295496F"><enum>(4)</enum><text>appropriate benchmarks to measure progress on achieving the improvements described in paragraphs
			 (2) and (3); and</text>
						</paragraph><paragraph commented="no" id="HA0DF6623315D454BA04ECA116106F8B5"><enum>(5)</enum><text display-inline="yes-display-inline">a plan to disseminate each summary under section 399OO–1(b)(1) and other relevant information
			 developed by the Working Group to the public, including health care
			 providers, public health departments, and other relevant medical groups.</text></paragraph></section></part><after-quoted-block>.</after-quoted-block></quoted-block>
		</section><section id="H425EFA3C753E41C898FAAD141842BB15"><enum>3.</enum><header>No additional authorization of appropriations</header><text display-inline="no-display-inline">No additional funds are authorized to be appropriated to carry out this Act and the amendment made
			 by this Act, and this Act and such amendment shall be<pagebreak></pagebreak> carried out using
			 amounts otherwise available for such purpose.</text>
		</section></legis-body>
	<attestation><attestation-group><attestation-date chamber="House" date="20140909">Passed the House of Representatives September 9, 2014.</attestation-date><attestor display="yes">Karen L. Haas,</attestor><role>Clerk</role></attestation-group></attestation>
</bill>


